Frontiers in Molecular Biosciences (Jun 2023)

When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment

  • Mario Wenger,
  • Sophie Grosse-Kathoefer,
  • Amin Kraiem,
  • Erica Pelamatti,
  • Natalia Nunes,
  • Lisa Pointner,
  • Lorenz Aglas

DOI
https://doi.org/10.3389/fmolb.2023.1204025
Journal volume & issue
Vol. 10

Abstract

Read online

Toll-like receptors of the human immune system are specialized pathogen detectors able to link innate and adaptive immune responses. TLR ligands include among others bacteria-, mycoplasma- or virus-derived compounds such as lipids, lipo- and glycoproteins and nucleic acids. Not only are genetic variations in TLR-related genes associated with the pathogenesis of allergic diseases, including asthma and allergic rhinitis, their expression also differs between allergic and non-allergic individuals. Due to a complex interplay of genes, environmental factors, and allergen sources the interpretation of TLRs involved in immunoglobulin E-mediated diseases remains challenging. Therefore, it is imperative to dissect the role of TLRs in allergies. In this review, we discuss i) the expression of TLRs in organs and cell types involved in the allergic immune response, ii) their involvement in modulating allergy-associated or -protective immune responses, and iii) how differential activation of TLRs by environmental factors, such as microbial, viral or air pollutant exposure, results in allergy development. However, we focus on iv) allergen sources interacting with TLRs, and v) how targeting TLRs could be employed in novel therapeutic strategies. Understanding the contributions of TLRs to allergy development allow the identification of knowledge gaps, provide guidance for ongoing research efforts, and built the foundation for future exploitation of TLRs in vaccine design.

Keywords